Related Experiment Video

Updated: Jul 10, 2026

Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

Probiotics and prebiotics in pediatrics: where are we now?

Hania Szajewska1

  • 12nd Department of Pediatrics, Medical University of Warsaw, Warsaw, Poland.

The Turkish Journal of Pediatrics
|November 10, 2007
PubMed

Insights

Probiotics and prebiotics show proven benefits for children

Area of Science:

  • Pediatric Gastroenterology
  • Microbiome Research
  • Nutritional Science

Background:

  • Probiotics and prebiotics are increasingly recognized for potential health benefits.
  • Scientific evidence for many claimed benefits remains limited.
  • Randomized controlled trials (RCTs) are crucial for validation.

Purpose of the Study:

  • To evaluate the evidence for probiotics and prebiotics in children.
  • To identify well-documented applications and areas needing further research.
  • To provide guidance on their use in pediatric populations.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) and meta-analyses.
  • Literature search of electronic databases and reference lists.
  • Evidence assessment up to April 2007.

Main Results:

  • The most robust evidence supports probiotics for acute infectious diarrhea and antibiotic-associated diarrhea in children.
  • Many other purported benefits of probiotics and prebiotics lack strong scientific confirmation.
  • A growing body of research suggests potential benefits beyond diarrhea management.

Conclusions:

  • Current evidence strongly supports specific probiotic strains for treating and preventing certain types of diarrhea in children.
  • Further research is needed to substantiate other health claims for probiotics and prebiotics.
  • Clearer guidelines are required for optimal use, including agent selection, dosage, and administration.

More Related Videos

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods08:38

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...